High Intensity Interval Training May Benefit Patients with Parkinson’s, Pilot Study Shows
High intensity interval training for 12 weeks can significantly improve neuronal activity and delay progression of Parkinson’s disease, correlating…
Articles by Alice Melão
Impaired Immune Cells May Contribute to Parkinson’s Progression, Study Suggests
Reduced viability and impaired activity of monocytes — a subset of immune cells that circulate in the blood — may…
Nuplazid ‘Significantly’ Slows Relapses in Dementia-Related Psychosis, Phase 3 Trial Shows
Interim results from the ongoing Phase 3 HARMONY study show that treatment with Nuplazid (pimavanserin) significantly delays time…
Phase 2 Trial of SEP-363856, Potential Oral Treatment of Parkinson’s Psychosis, Enrolling in US
A Phase 2 clinical trial of SEP-363856, an oral treatment candidate for people with Parkinson’s psychosis, is now recruiting patients…
Daily Use of Cala Trio Device Effectively Eases Hand Tremors, Trial Reports
Using Cala Health’s non-invasive therapeutic device Cala Trio for 40 minutes twice daily effectively helped to reduce hand tremors…
IRL752 May Help Manage Symptoms Unresponsive to L-Dopa, Phase 2 Data Suggests
The small molecule IRL752 may be a safe and effective treatment, which could potentially help manage symptoms known to…
Parkinson’s May Originate From Alpha-Synuclein Migrating From the Gut, Rat Study Shows
New experimental evidence collected from rats shows that alpha-synuclein — the protein that causes Parkinson’s disease — can…
Onstryv Now Available to Patients with Parkinson’s Disease in Canada
Patients in Canada with diagnosed Parkinson’s disease can now receive Onstryv (safinamide) to help manage their symptoms and…
Prevail’s Gene Therapy Candidate PR001 Granted FDA Fast Track Status
The U.S. Food and Drug Administration (FDA) has granted Fast Track designation to Prevail Therapeutics’ lead gene therapy…
Gene Therapy Used to Produce and Sustain Dopamine in Brains of Primate Model of Parkinson’s
Direct delivery of two dopamine-synthesizing enzymes to the midbrain, using a safe and inactive form of an adenovirus, was able…